Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs

P Nkansah, A Antipas, Y Lu, M Varma, C Rotter… - Journal of controlled …, 2013 - Elsevier
The aim of the present study was to develop and evaluate a novel drug solubilization
platform (so-called solid nanodispersion) prepared by a simple co-grinding and solvent-free …

[HTML][HTML] Drug transport mechanism of oral antidiabetic nanomedicines

E Gundogdu, A Yurdasiper - International Journal of Endocrinology …, 2014 - ncbi.nlm.nih.gov
Results: Insulin nanomedicines based on alginate-dextran sulfate core with a chitosan-
polyethylene glycol-albumin shell reduced glycaemia in a dose dependent manner. Orally …

Nano-encapsulation of EGCG in dextran 70-stabilized chitosan/SDS nanoparticles: Characterization, permeability behavior and oral bioavailability

J Yao, Y Jiang, H Dong, A Li - European Polymer Journal, 2024 - Elsevier
Epigallocatechin gallate (EGCG) declares massive health benefits, while poor oral
absorption and susceptibility to oxidation and degradation constrained clinical applications …

In vitro dissolution as a tool for formulation selection: telmisartan two-step IVIVC

A Ruiz Picazo, MT Martinez-Martinez… - Molecular …, 2018 - ACS Publications
The purpose of this investigation was to develop an exploratory two-step level A IVIVC for
three telmisartan oral immediate release formulations, the reference product Micardis, and …

Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins

PY Lin, EY Chuang, YH Chiu, HL Chen, KJ Lin… - Journal of Controlled …, 2017 - Elsevier
Sodium dodecyl sulfate (SDS) is generally regarded as a potent permeability enhancer in
oral formulations; however, one concern related to the use of any permeation enhancer is its …

Quantitative analysis of excipients to the permeability of BCS class III drugs

S Wang, D Liu, D Ouyang - International Journal of Pharmaceutics, 2025 - Elsevier
BCS III drugs exhibit high solubility and low permeability, and some excipients were
reported to increase their permeability. Although some permeability-enhancing excipients …

Investigating the Discriminatory Power of BCS-Biowaiver in Vitro Methodology to Detect Bioavailability Differences between Immediate Release Products Containing …

S Colon-Useche, I Gonzalez-Alvarez… - Molecular …, 2015 - ACS Publications
The purpose of this work is to investigate the discriminatory power of the Biopharmaceutics
Classification System (BCS)-biowaiver in vitro methodology, ie, to investigate if a BCS …

Rhamnolipids enhance epithelial permeability in Caco-2 monolayers

L Jiang, X Long, Q Meng - International journal of pharmaceutics, 2013 - Elsevier
This work aimed to evaluate the applicability of rhamnolipids as permeation enhancers for
oral drugs. In this study, rhamnolipids were found to effectively increase the paracellular and …

Rat intestinal drug permeability: A status report and summary of repeated determinations

IR Dubbelboer, D Dahlgren, E Sjögren… - European Journal of …, 2019 - Elsevier
Intestinal permeability is a key biopharmaceutical variable in pharmaceutical research and
development, and regulatory assessment. In situ rat models are often used to predict the …

“Development of fixed dose combination products” workshop report: considerations of gastrointestinal physiology and overall development strategy

B Hens, M Corsetti, M Bermejo, R Löbenberg… - 2019 - Springer
The gastrointestinal (GI) tract is one of the most popular and used routes of drug product
administration due to the convenience for better patient compliance and reduced costs to the …